Emami Limited Reports Q2 Results, Declares Rs 4 Per Share Interim Dividend

1 min read     Updated on 10 Nov 2025, 02:49 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Emami Limited has declared a first interim dividend of Rs 4 per equity share for FY 2025-26, payable by December 9, 2025. The company has made strategic investments by converting loan receivables into equity in Brillare Science Limited and Helios Lifestyle Limited, and into Optionally Convertible Debentures of Cannis Lupus Services India Private Limited. Additional investments were made in Cannis Lupus Services. Emami's Assam facility continues to benefit from tax advantages, resulting in MAT credit recognition of Rs 3,775.00 lacs for the half-year.

24311969

*this image is generated using AI for illustrative purposes only.

Emami Limited , a leading Indian personal care and healthcare company, has reported its financial results for the quarter and half-year ended September 30, 2025, along with several key corporate actions.

Interim Dividend Announcement

The Board of Directors has approved a first interim dividend of Rs 4 per equity share (400%) for the financial year 2025-26. The dividend will be payable on or before December 9, 2025, with November 14, 2025 set as the record date. This dividend will be distributed across 43.65 crore equity shares.

Corporate Actions and Investments

During the period, Emami made several strategic financial moves:

  • Converted loan receivables into equity investments in two subsidiaries:
    • Brillare Science Limited: Rs 2,153.00 lacs
    • Helios Lifestyle Limited: Rs 855.00 lacs
  • Converted Rs 820.00 lacs of loan receivables into Optionally Convertible Debentures of Cannis Lupus Services India Private Limited
  • Made additional investments of Rs 400.00 lacs in Cannis Lupus Services India Private Limited

Tax Benefits

The company's manufacturing facility in Assam continues to benefit from income tax advantages under section 80IE. This resulted in the recognition of MAT (Minimum Alternate Tax) credit of Rs 3,775.00 lacs for the six-month period.

Financial Performance Overview

While detailed financial metrics for the quarter were not provided in the update, the company has reported its unaudited financial results for the quarter and half-year ended September 30, 2025.

Outlook

Emami's strategic investments in its subsidiaries and the conversion of loan receivables into equity and debentures indicate a focus on strengthening its group companies. The dividend payout and tax benefits from its Assam facility may be seen as positive factors for the company's financial stability and shareholder value.

Investors and analysts may look forward to more detailed financial metrics to assess the company's performance in the context of current market conditions and its growth strategies.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-0.35%+1.22%-2.19%-18.60%-19.06%+36.15%

Emami Limited Secures 'IND AA+/Stable/IND A1+' Rating for INR 1,800 Million Bank Loan Facilities

1 min read     Updated on 30 Oct 2025, 09:39 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

India Ratings and Research (Ind-Ra) has assigned a 'IND AA+/Stable/IND A1+' rating to Emami Limited's INR 1,800 million bank loan facilities. The rating reflects Emami's robust financial health and strong market position in the FMCG sector. The company reported revenue of INR 38.10 billion and EBITDA of INR 10.30 billion in FY25, with an EBITDA margin of 26.90%. Emami maintains market leadership in several niche product categories, including Navratna Cooling Oil (68% market share) and Boro Plus Antiseptic Cream (60% market share). The company's strengths include a diverse product portfolio, strong R&D focus, and extensive distribution network. Emami also maintains a net cash position of INR 6.30 billion and a gross interest coverage of 110x in FY25. However, the company faces challenges such as intense competition and exposure to raw material cost fluctuations.

23386148

*this image is generated using AI for illustrative purposes only.

India Ratings and Research (Ind-Ra) has assigned a strong credit rating to Emami Limited 's bank loan facilities, reflecting the company's robust financial health and market position in the FMCG sector.

Credit Rating Details

Instrument Type Size of Issue (INR million) Rating Assigned Rating Action
Bank loan facilities 1,800 IND AA+/Stable/IND A1+ Assigned

Key Financial Highlights

  • Revenue: INR 38.10 billion in FY25 (up from INR 35.80 billion in FY24)
  • EBITDA: INR 10.30 billion in FY25 (increased from INR 9.50 billion in FY24)
  • EBITDA Margin: 26.90% in FY25 (slight improvement from 26.50% in FY24)
  • Interest Coverage: 110x in FY25 (up from 95x in FY24)
  • Net Leverage: Maintained net cash position

Market Leadership

Emami continues to dominate several niche product categories:

Product Market Share (FY25)
Navratna (Cooling Oil) 68.00%
Boro Plus (Antiseptic Cream) 60.00%
Smart and Handsome (Male Grooming) 74.00%
Zandu Balm & Mentho Plus (Pain Management) 55.00%

Business Strengths

  1. Strong Product Portfolio: Over 1,100 SKUs across various segments.
  2. R&D Focus: 137 scientists and field experts at R&D centers in Mumbai and Kolkata.
  3. Robust Distribution Network: Direct and indirect reach of 5.4 million outlets, with 3,400 distributors.
  4. International Presence: 17% of revenue from international business, spanning over 70 countries.
  5. Omni-channel Growth: E-commerce and modern trade contribute 23% to revenue.

Financial Position

  • Net Cash Position: INR 6.30 billion at FYE25
  • Gross Interest Coverage: 110x in FY25
  • Working Capital Cycle: 80 days in FY25
  • ROCE: 32.10% in FY25

Challenges and Risks

  1. Intense competition in the FMCG sector
  2. Exposure to raw material cost fluctuations
  3. High dependence on seasonal products (43% of portfolio)
  4. Limited increase in category penetration for some products

Emami's strong credit rating reflects its market leadership, robust financial performance, and strategic focus on niche product categories. The company's ability to maintain high margins and a net cash position, despite competitive pressures and strategic acquisitions, underscores its financial strength. However, the FMCG sector's inherent challenges and the company's exposure to seasonal products remain key areas to watch.

As Emami continues to expand its international presence and focus on strategic acquisitions, it will be crucial for the company to maintain its strong market position while navigating the evolving consumer landscape and potential economic uncertainties.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-0.35%+1.22%-2.19%-18.60%-19.06%+36.15%
More News on Emami
Explore Other Articles
520.35
-1.85
(-0.35%)